Reading FEED? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track FEED free→Reading FEED? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track FEED free→QuarterlyIQ Insights · FEED
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. First Amendment to Amended and Restated Employment Agreement with Doron Besser, M.D. On February 2, 2026, ENvue Medical Israel, Ltd., a wholly owned subsidiary of ENvue Medical, Inc. (the “Company ”), entered into a first amendment (the “ Amendment ”) to that certain Amended and Restated Employment Agreement with Doron Besser, dated as of December 17, 2025 (as amended, the “ Besser Employme…
Material Modification to Rights of Security Holders. The matters described in
Entry into a Material Definitive Agreement. As previously disclosed in the Current Report on Form 8-K filed on July 22, 2025, in connection with the closing of the issuance and sale of the ENvue Medical,, Inc.’s (the “ Company ”) Series H Convertible Preferred Stock, par value $0.001 per share (the “Preferred Stock”) on July 18, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series H Convertible Preferred Stock with the Secretary of State of…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 24, 2025, the Board of Directors of ENvue Medical, Inc. (the “ Company ”) approved the amendment and restatement of the 2024 Long Term Incentive Plan (as amended and restated, the “ Amended and Restated Plan ”). The Amended and Restated Plan amends the definition of Awards (as defined in the Amended and Restated Plan), for Israeli law…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Amended and Restated Employment Agreement with Doron Besesr, M.D. On December 17, 2025 (the “ Effective Date ”), ENvue Medical Israel, Ltd., a wholly owned subsidiary of ENvue Medical, Inc. (the “Company ”), entered into an amended and restated employment agreement (the “ Besser Employment Agreement ”) with Doron Besser, M.D., Chief Executive Officer of the Company, which such agreement ame…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on , on October 30, 2025, each of Christopher Fashek, Thomas Mika, Martin Goldstein, M.D. and Brian Murphy advised the Board of Directors (the “Board”) of NanoVibronix, Inc. (the “Company”) that they do not intend to stand for reele…
Entry into a Material Definitive Agreement. On September 16, 2025, NanoVibronix, Inc. (the “ Company ”) entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor, pursuant to which the Company agreed to issue and sell (i) 74,114 shares (the “ Shares ”) of the Company’s common stock, $0.001 par value per share (the “ Common Stock ”), and (ii) prefunded warrants (the “ Prefunded Warrants ”) to purchase up to 217,090 shares of Common Stock (the…
Changes in Registrant’s Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm On August 12, 2025, the Audit Committee of the Board of Directors (the “ Committee ”) of NanoVibronix, Inc. (the “ Company ”) approved the dismissal of Zwick CPA PLLC (“ Zwick ”) as the Company’s independent registered public accounting firm, effective as of the same date. The reports of Zwick on the Company’s consolidated financial statements for the two most recent fiscal years, end…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On August 11, 2025 (the “ Brown Effective Date ”), the Company entered into an amended and restated employment agreement (the “ Brown Employment Agreement ”) with Stephen Brown, Chief Financial Officer of the Company, which such agreement amends, restates and those certain employment agreements dated September 20, 2024, January 1, 2022, and October 5, 2020. Pursuant to the terms of the Brow…
Material Modification to Rights of Security Holders. To the extent required by
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 24, 2025, the Board of Directors of NanoVibronix, Inc. (the “ Company ”) appointed Rita Silberberg as the Executive Vice President of Finance and Chief Accounting Officer of the Company, effective as of the same date. Additionally, on July 24, 2025, Ms. Silberberg was appointed Corporate Secretary of the Company, effective as of the same da…
Material Modification to Rights of Security Holders. The matters described in
Unregistered Sales of Equity Securities The matters described in
Entry into a Material Definitive Agreement. Securities Purchase Agreement On July 18, 2025, NanoVibronix, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with a certain institutional investor (the “ Investor ”), pursuant to which it agreed to sell to the Investors (i) an aggregate of 8,889 shares of the Company’s newly-designated Series H Convertible Preferred Stock, with a par value of $0.001 per share and a stated value of $1,000 per share (t…
Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet Arrangement of a Registrant The matters described in
Other Events. On July 11, 2025, NanoVibronix, Inc. (the “ Company ”) opened and adjourned its Special Meeting of Stockholders (the “ Special Meeting ”) due to an absence of a quorum in accordance with the Company’s Amended and Restated Bylaws, as amended, without any business being conducted. The Special Meeting will be reconvened virtually with respect to all proposals at 10:00 a.m. Eastern Time on Thursday, July 17, 2025 (the “ Reconvened Special Meeting ”), at www.virtualshareholdermeeting…
Material Modification to Rights of Security Holders To the extent required by
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 4, 2025, the Board of Directors (the “ Board ”) of NanoVibronix, Inc. (the “ Company ”) appointed Doron Besser, M.D., a director of the Board and Chief Executive Officer and President of the Company’s wholly-owned subsidiary, ENvue Medical Holdings LLC (“ ENvue ”), as the Company’s Chief Executive Officer (“ CEO ”), effective as of the same…
Material Modification to Rights of Security Holders. The matters described in
Entry into a Material Definitive Agreement. Underwritten Public Offering On May 14, 2025, NanoVibronix, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) by and between the Company and Dawson James Securities, Inc. as representative of the underwriters named on Schedule I of the Underwriting Agreement (the “ Representative ”), pursuant to which the Company agreed to issue in a firm commitment underwritten offering (the “ Offering ”) (i) 400,000 sha…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Entry into a Material Definitive Agreement. Promissory Note On April 11, 2025, ENvue Medical Holdings, Corp. (“ ENvue ”), a wholly-owned subsidiary of NanoVibronix, Inc. (the “ Company ”), issued a promissory note (the “ Note ”) to Alpha Capital Anstalt (the “ Lender ”) in the principal amount of $360,000 (the “ Principal Amount ”), together with all accrued interest thereon. The Note has a maturity date of June 11, 2025 (the “ Maturity Date ”) and on the Maturity Date, the aggregate unpaid P…
Departure of Directors or Certain Officers, Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately. Ms Cassirer served as a member of the audit committee, corporate governance and nominating committee, and compensation committee. Ms. Cassirer’s resignation was not…
Material Modification to Rights of Security Holders. To the extent required by
of this Current Report on Form 8-K, including the information in the press release attached as Exhibit 99.4 to this Current Report on Form 8-K, shall not be deemed to be incorporated by reference in the filings of the Company under the Securities Act of 1933, as amended. Forward Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding: s…
Importance-ranked changes since the prior daily snapshot.
Valuation label changed from 'None' to 'inexpensive'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.